Issue: May 2014
May 01, 2014
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
ZEUS
Issue: May 2014
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Trial examined zotarolimus-eluting Endeavor stent implantation in patients at low restenosis or at high bleeding or thrombotic risk and the effect on major adverse cardiac events at 1 year.